AHNAK2 and neoplasm: This stemness-associated signature integrates developmental drivers such as PTPRH, AHNAK2, PCDH7, metabolic regulators CPS1, SFTPB, and hypoxia-responsive factors such as TCN1, TMPRSS11E, reflecting the multifaceted nature of OSA-induced tumor evolution.